The budesonide market is growing as asthma, chronic obstructive pulmonary disease, allergic rhinitis, and inflammatory conditions continue to create demand for effective corticosteroid therapies. The market was valued at USD 3.3 billion in 2024 and is projected to reach USD 5 billion by 2035, growing at a CAGR of 3.9%. 1208
The Budesonide Market includes inhalation products, nasal sprays, oral...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek